Sort
48,018 grants matching “immunotherapy”
POLYVALENT VACCINE--PHASE III TRIAL IN STAGE IV MELANOMA
$1,108,592John Wayne Cancer Institute · R01 · FY2002 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,107,978Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Strategies for Cancer Immunotherapy Clinical Trials
$1,107,978Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,107,849Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Strategies for Cancer Immunotherapy Clinical Trials
$1,107,849Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Finding Sleeping Beauty: T Cell Biosensors for Dormant Cancer Detection
$1,107,400Gabriel A Kwong · Georgia Institute Of Technology · DP1 · FY2022 · CA
Finding Sleeping Beauty: T Cell Biosensors for Dormant Cancer Detection
$1,107,400Gabriel A Kwong · Georgia Institute Of Technology · DP1 · FY2023 · CA
Eliminating Interference from Autofluorescence in Flow Cytometry
$1,107,310Giacomo Vacca · Kinetic River Corporation · R44 · FY2023 · GM
Core C - in vivo Efficacy Testing (CIIG)
$1,107,241Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2025 · AI
NRG Oncology Network Group Operations Center
$1,106,894Norman Wolmark · Nrg Oncology Foundation, Inc. · U10 · FY2024 · CA
An Off-the-Shelf tumor cell vaccine with HLA-matching alleles for personalized treatment of advanced metastatic prostate cancer.
$1,106,781William Valentine Williams · Briacell Therapeutics Corp · R44 · FY2025 · CA
Combinational Immunotherapies to Amplify Vaccine Induced Immunity
$1,106,675Elizabeth Marion Jaffee · Johns Hopkins University · U19 · FY2009 · CA
Bastyr/UW Oncomycology Translational Research Center
$1,106,200Leanna J Standish · Bastyr University · U19 · FY2011 · AT
Metabolic regulation of T cell effector function and anti-tumor immunotherapy
$1,105,926Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Immunologic Correlates of Immunization for Cancer
$1,105,804University Of Washington · U54 · FY2004 · CA
PROGRAM PROJECT IN ALLOGENEIC STEM CELL TRANSPLANTATION
$1,104,969Dana-Farber Cancer Institute · P01 · FY2002 · AI
Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever
$1,104,705Thomas William Geisbert · University Of Texas Med Br Galveston · R01 · FY2021 · AI
NORTHERN CALIFORNIA PEDIATRIC AIDS TREATMENT CENTER
$1,104,622University Of California San Francisco · U01 · FY2000 · AI
Tumor Plasticity
$1,104,176Dario C. Altieri · Wistar Institute · R35 · FY2019 · CA
Targeting the Epigenome for Lung Cancer Therapy
$1,103,712David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Broad Spectrum Neutralizing Human Abs to SARS and Related Coronaviruses
$1,103,251Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2012 · AI
VACCINE IMMUNOTHERAPY FOR PROSTATE CANCER
$1,102,802The University Of Iowa · · FY2008 · Department of the Army
Profiling cancer neoantigen repertoires and validating immunotherapy targets
$1,101,954Martin W McIntosh · Fred Hutchinson Cancer Research Center · U01 · FY2013 · CA
Targeting DKK1 with a DNA Vaccine to Prevent Development of Multiple Myeloma
$1,101,494Xiangwei Wu · University Of Tx Md Anderson Can Ctr · N01 · FY2023 · CA
NIH Chronic GVHD Study Group
$1,101,016Steven Pavletic · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA